Profarma has been a leading force in the pharmaceutical and personal care product distribution industry in Brazil for over 52 years. The company's wide range of offerings, which includes medicines, health and beauty care items, oncological and dermatological products, as well as toiletries, vaccines, prostheses, and hormones, has contributed to its strong presence in the South, Southeast, Northeast, and Center-West regions of Brazil. The last investment received by Profarma was in the form of a Post-IPO Equity investment on 24 March 2014, with Cencora being the investor. Profarma's long-standing history, strong market presence, and diverse product portfolio make it an attractive prospect for venture capital firms seeking opportunities in the pharmaceutical distribution industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity | Unknown | 1 | Cencora | 24 Mar 2014 |
No recent news or press coverage available for Profarma.